We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+9.8%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.34B
AUM Growth
+$161M
Cap. Flow
+$69M
Cap. Flow %
5.14%
Top 10 Hldgs %
30.2%
Holding
355
New
45
Increased
26
Reduced
83
Closed
57

Sector Composition

Rank Sector Weight
1 Financials 26.53%
2 Healthcare 16.95%
3 Consumer Discretionary 10.09%
4 Energy 6.1%
5 Materials 5.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TIOA
26
DELISTED
Tio Tech A Class A Ordinary Share
TIOA
$15.3M 1.14%
1,500,000
-500,000
-25% -$5.08M
TCOA
27
DELISTED
Zalatoris Acquisition Corp.
TCOA
$15.2M 1.13%
1,484,799
HGV icon
28
Hilton Grand Vacations
HGV
$3.6B
$15.2M 1.13%
341,485
+16,485
+5% +$747K
PANA
29
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
$15.1M 1.13%
1,480,000
BLDR icon
30
Builders FirstSource
BLDR
$8.09B
$14.2M 1.06%
160,000
-80,000
-33% -$6.34M
MBC icon
31
MasterBrand
MBC
$1.21B
$14.1M 1.05%
1,750,000
-2,350,000
-57% -$20.7M
HES
32
PUT
DELISTED
Hess
HES
$13.2M 0.99%
+100,000
New +$13.9M
GOOG icon
33
PUT
Alphabet (Google) Class C
GOOG
$4.58T
$12M 0.89%
115,000
-30,000
-21% -$2.9M
TGTX icon
34
TG Therapeutics
TGTX
$7.15B
$11.7M 0.87%
775,000
-475,000
-38% -$7.22M
GTAC
35
DELISTED
Global Technology Acquisition Corp. I Class A Ordinary Shares
GTAC
$10.8M 0.81%
1,035,000
-500,000
-33% -$5.19M
APLS
36
DELISTED
Apellis Pharmaceuticals
APLS
$10.6M 0.79%
160,000
-15,000
-9% -$866K
ARYE
37
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
$10.2M 0.76%
1,000,000
BHF icon
38
Brighthouse Financial
BHF
$3.59B
$9.92M 0.74%
+225,000
New +$11.8M
R icon
39
Ryder
R
$10.3B
$9.82M 0.73%
+110,000
New +$10.1M
VKTX icon
40
Viking Therapeutics
VKTX
$3.88B
$9.66M 0.72%
580,000
+551,000
+1,900% +$5.69M
PHAT icon
41
Phathom Pharmaceuticals
PHAT
$684M
$9.46M 0.7%
1,325,500
-24,500
-2% -$215K
BLDR icon
42
PUT
Builders FirstSource
BLDR
$8.09B
$9.32M 0.69%
105,000
+50,000
+91% +$3.96M
MRNA icon
43
PUT
Moderna
MRNA
$23B
$9.21M 0.69%
+60,000
New +$9.9M
IMTX icon
44
Immatics
IMTX
$1.26B
$9.21M 0.69%
1,334,937
+34,937
+3% +$286K
CRESY
45
Cresud
CRESY
$780M
$9M 0.67%
1,470,676
-12,525
-0.8% -$82K
MGTX icon
46
MeiraGTx Holdings
MGTX
$1.13B
$8.66M 0.65%
1,675,000
-25,000
-1% -$173K
MDGL icon
47
PUT
Madrigal Pharmaceuticals
MDGL
$11.7B
$8.48M 0.63%
+35,000
New +$9.54M
COIN icon
48
PUT
Coinbase
COIN
$39.8B
$8.45M 0.63%
+125,000
New +$7.49M
SNDX icon
49
Syndax Pharmaceuticals
SNDX
$1.73B
$8.24M 0.61%
390,000
-180,000
-32% -$4.48M
GEHC icon
50
PUT
GE HealthCare
GEHC
$31.5B
$8.2M 0.61%
+100,000
New +$7.14M

Similar funds

683 Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, 683 Capital Management held 355 positions worth $1.34B, up 14% from $1.18B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

683 Capital Management deployed $69M of net new capital in Q1 2023, opening 45 new positions and adding to 26 existing holdings. Its largest new stake was BorgWarner: 624,800 shares worth $27M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, down from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Enova International, an estimated $30.4M trimmed.

  • 683 Capital Management's largest Q1 2023 buy was BorgWarner: 624,800 shares worth $27M.
  • 683 Capital Management added most to Alphabet (Google) Class A in Q1 2023, an estimated $15.6M increase.
  • 683 Capital Management's biggest Q1 2023 reduction was Enova International, cutting an estimated $30.4M.
  • 683 Capital Management fully exited Rocket Internet Growth Opportunities Corp. in Q1 2023, selling an estimated $15M.
  • 683 Capital Management's ten largest holdings make up 30% of its $1.34B portfolio in Q1 2023.
  • 683 Capital Management opened 45 new positions and closed 57 in Q1 2023.
  • 683 Capital Management's portfolio value rose 14% quarter-over-quarter to $1.34B.

Based on 683 Capital Management's 13F filing for Q1 2023, filed 15 May 2023.